Karen M. Doherty, MRCP; Laura Silveira-Moriyama, PhD; Laura Parkkinen, PhD; et al.
free access
has multimedia
JAMA Neurol. 2013;70(5):571-579. doi:10.1001/jamaneurol.2013.172
Doherty and colleagues investigated whether parkin-linked parkinsonism is a different clinicopathologic entity to Parkinson disease. J. Eric Ahlskog, PhD, MD, provides a related editorial.
-
Video:
Patient (Case 5) Aged 56 Years, Untreated
-
Video:
Patient (case 5) Aged 62 Years, Being Treated With Levodopa
Kenn Freddy Pedersen, MD, PhD; Jan Petter Larsen, MD, PhD; Ole-Bjorn Tysnes, MD, PhD; et al.
free access
JAMA Neurol. 2013;70(5):580-586. doi:10.1001/jamaneurol.2013.2110
In a population-based cohort, Pederson et al evaluated the incidence of mild cognitive impairment and its progression to dementia during a 3-year study in 182 patients with Parkinson disease.
Yo-El S. Ju, MD; Jennifer S. McLeland, MSW, MA; Cristina D. Toedebusch, BS; et al.
free access
has audio
JAMA Neurol. 2013;70(5):587-593. doi:10.1001/jamaneurol.2013.2334
In a cross-sectional study, Ju et al test whether A尾 deposition in preclinical Alzheimer disease, prior to the appearance of cognitive impairment, is associated with changes in quality or quantity of sleep.
-
Podcast:
Sleep Quality and Preclinical Alzheimer Disease
Maureen Handoko, PhD; Marianne Grant, BA; Michael Kuskowski, PhD; et al.
free access
JAMA Neurol. 2013;70(5):594-599. doi:10.1001/jamaneurol.2013.48
Handoko and colleagues investigated 2 specific amyloid-尾 (A尾) oligomers, A尾 trimers and A尾*56, in human cerebrospinal fluid (CSF); evaluated the effects of aging and Alzheimer disease; and aimed to obtain support for the hypothesis that they may be pathogenic by determining their relationships to CSF tau.
Karen M. Rodrigue, PhD; Jennifer R. Rieck, MS; Kristen M. Kennedy, PhD; et al.
free access
JAMA Neurol. 2013;70(5):600-606. doi:10.1001/jamaneurol.2013.1342
In a cross-sectional study, Rodrigue et al investigate risk factors for 尾-amyloid deposition in cognitively healthy middle-aged and older adults.
Sang-Soo Lee, MD; Hye Jin Lee, MSc; Jin-Mo Park, MD; et al.
free access
has multimedia
JAMA Neurol. 2013;70(5):607-615. doi:10.1001/jamaneurol.2013.1250
Lee et al perform whole-exome sequencing to determine the relationship between hereditary motor and sensory neuropathy with proximal dominance and a mutation in the TRK-fused gene in a Korean family.
Deniz Erten-Lyons, MD; Hiroko H. Dodge, PhD; Randall Woltjer, MD, PhD; et al.
free access
JAMA Neurol. 2013;70(5):616-622. doi:10.1001/jamaneurol.2013.1957
Erten-Lyons et al examine the association between brain atrophy during life and neuropathology in an elderly population.
Niraj Mistry, MA; Jennifer Dixon, PhD; Emma Tallantyre, PhD; et al.
free access
JAMA Neurol. 2013;70(5):623-628. doi:10.1001/jamaneurol.2013.1405
In a prospective longitudinal cohort study, Mistry and coauthors assess the diagnostic value of visualizing central veins in brain lesions with magnetic resonance imaging for patients with possible multiple sclerosis for which a diagnosis is uncertain.
Jeffrey M. Gelfand, MD; Bruce A. Cree, MD, PhD, MRC; Rachel Nolan, BA; et al.
free access
JAMA Neurol. 2013;70(5):629-633. doi:10.1001/jamaneurol.2013.1832
Gelfand and colleagues conducted an observational, retrospective study to establish whether microcystic inner nuclear layer abnormalities occur in neuromyelitis optica (NMO).